Dr. Tom Keenan is an award-winning journalist, public speaker, professor in the School of Architecture, Planning and ...
They are more likely to turn to alcohol, cigarettes, or drugs in an attempt to cope with these negative ... risk factors for ...
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...
Barbiturates are central nervous system depressant drugs that have been used to treat seizures, insomnia, migraines, and more. However, they are not as commonly used today due to their side effects ...
The Food and Drug Administration (FDA) is proposing to remove from the market a common ingredient found in most oral over-the ...
An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.
Many types of medications, including over-the-counter (OTC) and prescription drugs, can help relieve joint pain due to ...
Brendon Yee, PhD, professor and respiratory and sleep physician, Woolcock Institute of Medical Research, discusses the ...
Presentations include results from two pivotal studies (Studies 501 and 502) evaluating lumateperone as an adjunctive therapy to antidepressants ...
For the third quarter of 2024, the Company reported a net loss attributable to common stockholders of $4.9 million, or $5.79 per share, compared to $7.9 million, or $14.20 per share in the third ...
Investigators calculated annual OOP and total medication costs for five common neurological diseases. These included 186,144 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback